Aberdeen Group’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
Other funds holding CELG
FP
HCM
PCMC
WCG
Aberdeen Group's CELG Position: Q4 2019 in Review
Aberdeen Group sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 316,410 shares — an estimated $31.4M sold.
Aberdeen Group first reported a position in CELG in Q3 2017 and held it in 9 quarters. The position peaked at $520M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Aberdeen Group reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Aberdeen Group sold 316,410 Celgene Corp shares in Q4 2019, an estimated $31.4M.
- Aberdeen Group first reported a position in Celgene Corp in Q3 2017 and held it in 9 quarters.
- Aberdeen Group's Celgene Corp position peaked at $520M in Q3 2017.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Aberdeen Group's 13F filing for Q4 2019, filed 18 Feb 2020.